Havrix – Hepatitis A Injection
HEPATITIS A (HAVRIX) INJECTION – TREATMENT FOR PREVENTION OF HEPATITIS A INFECTION
Hepatitis A, a devastating liver illness brought on by the hepatitis A virus, is prevented with the Havrix 720 Junior Monodose Vaccine (HAV). It spreads from person to person when infected food or drink is in touch with the body. It is administered as two doses spaced six months apart and is safe and effective. For long-term defence, both shots are required.
An injection of the Havrix 720 Junior Monodose Vaccine is administered by a physician or nurse. Children from 12 months old to 18 years old receive this immunisation. The vaccine is also available for adults who wish to be protected against hepatitis A but have never had a vaccination. The most effective method of preventing hepatitis A is immunisation.
USES OF HEPATITIS A (HAVRIX) INJECTION
- Prevention of Hepatitis A infection
WORKS OF HEPATITIS A (HAVRIX) INJECTION
An inactivated vaccination is the Havrix 720 Junior Monodose Vaccine (made from a dead virus). By generating antibodies, which are proteins that defend against infection brought on by viruses contained in the vaccination, it aids in the development of immunity.
SIDE EFFECTS OF HEPATITIS A (HAVRIX) INJECTION
- Sore throat
- Abdominal pain
- Anaphylactic reaction
- Loss of appetite
- Feeling of discomfort
- Erythema (skin redness)
- Flushing (sense of warmth in the face, ears, neck and trunk)
WARNING & PRECAUTIONS
The ability to drive may be affected by the Havrix 720 Junior Monodose Vaccine, however, this is unknown. If you encounter any symptoms that impair your focus or reaction time, avoid operating a vehicle.
It is widely accepted that using the Havrix 720 Junior Monodose Vaccine during pregnancy is safe. There are human research, despite the fact that animal studies on the growing foetus have shown little to no negative consequences.
- Breast feeding
Use of the Havrix 720 Junior Monodose Vaccine during nursing is most likely safe. Inferred from scant human evidence, the medicine does not appear to pose a major risk to the developing foetus.